Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Clinical trial NCT03913312 · UNKNOWN

Trial details

NCT number: NCT03913312
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2018-09-01
Primary completion: 2019-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.